Aspergillosis.
Morrison
C
C
Johns Hopkins University, Johns Hopkins Oncology Center Hospital, Baltimore, MD 21205, USA.
Lew
E
E
D000553:Ambulatory Care / Q000379:methods; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D017053:Infection Control / Q000379:methods; D008172:Lung Diseases, Fungal / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D011013:Pneumonectomy; D012307:Risk Factors; D018877:Sick Building Syndrome / Q000150:complications; D013256:Steroids
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D013256:Steroids